VJHemOnc is committed to improving our service to you

iwCLL 2019 | Is MRD ready for clinical practice?

VJHemOnc is committed to improving our service to you

Lydia Scarfò

Lydia Scarfò, MD, Vita-Salute San Raffaele University, Milan, Italy shares her opinion on measurable residual disease (MRD) and how we might be able to integrate this intermediate endpoint into clinical practice. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter